title: Dabigatran Versus Warfarin in Relation to Renal Function in Patients With Atrial Fibrillation.
authors.forename: Freddy
authors.initials: F
authors.lastname: Del-Carpio Munoz
authors.forename: Xiaoxi
authors.initials: X
authors.lastname: Yao
authors.forename: Neena S
authors.initials: NS
authors.lastname: Abraham
authors.forename: M Fernanda
authors.initials: MF
authors.lastname: Bellolio
authors.forename: Alejandro A
authors.initials: AA
authors.lastname: Rabinstein
authors.forename: Samuel J
authors.initials: SJ
authors.lastname: Asirvatham
authors.forename: Robert D
authors.initials: RD
authors.lastname: McBane
authors.forename: Bernard J
authors.initials: BJ
authors.lastname: Gersh
authors.forename: Nilay D
authors.initials: ND
authors.lastname: Shah
authors.forename: Peter A
authors.initials: PA
authors.lastname: Noseworthy
mesh_terms: D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D000991:Antithrombins / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D000069604:Dabigatran / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*; D014859:Warfarin / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D000991:Antithrombins; D014859:Warfarin; D000069604:Dabigatran